In 2016, an estimated 70 580 people in the USA will have been diagnosed and 20 150 will have died from non-Hodgkin lymphoma (NHL).¹ NHL incidence rates increased over the latter half of the 20th century and only recently stabilized. In parallel, NHL survival rates began improving in the 1990 s with the advent of improved treatment strategies, leading to the current 5-year survival rate of 72%.² These trends have led to a growth in the number of NHL survivors, estimated at over 630 000 in the USA in 2013.³

中文翻译：

---

队列资料：卓越的淋巴瘤专业研究计划（SPORE）分子流行病学资源（MER）队列研究

2016年，在美国估计将诊断出70580人，其中20150人会死于非霍奇金淋巴瘤（NHL）。¹ NHL发病率在20世纪下半叶有所增加，直到最近才稳定下来。同时，随着改良治疗策略的出现，NHL生存率在1990年代开始提高，导致目前的5年生存率达到72％。^2个这些趋势已导致在NHL幸存者的数目的增长，在2013年估计在美国超过630 000 ³